Tandem Diabetes Care Inc (STU:TD5A)
€ 29.15 -1.65 (-5.36%) Market Cap: 1.92 Bil Enterprise Value: 1.92 Bil PE Ratio: 0 PB Ratio: 8.66 GF Score: 82/100

Tandem Diabetes Care Inc at Citi Unplugged Medtech and Life Sciences Access Day Transcript

Feb 29, 2024 / 06:00PM GMT
Release Date Price: €24.34 (-2.01%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

So welcome back. We're in the afternoon sessions. I'm thrilled to have the management of Tandem here. And Lee and John, thank you for traveling to warm New York, and especially from your cold Southern California. Anyway, I want to -- I'm going to start big picture...

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Before you ask any questions, we have a new corporate counsel, and I want to read this.

Either read this. Today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, product development time lines and the financial performance and operating plans, and they speak only as of today's date. These statements are not guarantees of future performance and involve a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied in our forward-looking statements. Further details related to our forward-looking statements can be found on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot